NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its third-quarter revenues jumped 68 percent year over year on sales of its MaterniT21 Plus laboratory-developed test.

The San Diego-based firm brought in total revenues of $22.9 million for the three months ended Sept. 30, up from $13.6 million for the third quarter of 2011 but falling shy of the consensus Wall Street estimate for revenues of $23.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.